Skip to main content
Premium Trial:

Request an Annual Quote

Correction: Dec 9, 2004

Premium

In the 11/18/2004 Pharmacogenomics Reporter, the article “Diagnostics Eye Fragile-X Market After Wide Adoption of CF-Screen” incorrectly quoted Paul Billings, senior geneticist at LabCorp as saying “[Fragile-X testing] is clearly part of the standard of care for the workup of a child with proven environmental delay.” The quote should read: “[Fragile-X testing] is clearly part of the standard of care for the workup of a child with proven developmental delay.”

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more